Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Anaptysbio (ANAB) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Anaptysbio (ANAB) over the last 12 years, with Q3 2025 value amounting to $428000.0.

  • Anaptysbio's Accumulated Depreciation & Amortization fell 715.84% to $428000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $428000.0, marking a year-over-year decrease of 715.84%. This contributed to the annual value of $606000.0 for FY2024, which is 705.52% down from last year.
  • Anaptysbio's Accumulated Depreciation & Amortization amounted to $428000.0 in Q3 2025, which was down 715.84% from $288000.0 recorded in Q2 2025.
  • Anaptysbio's Accumulated Depreciation & Amortization's 5-year high stood at $675000.0 during Q4 2022, with a 5-year trough of $125000.0 in Q1 2021.
  • Over the past 5 years, Anaptysbio's median Accumulated Depreciation & Amortization value was $329000.0 (recorded in 2023), while the average stood at $377842.1.
  • As far as peak fluctuations go, Anaptysbio's Accumulated Depreciation & Amortization plummeted by 1071.43% in 2021, and later skyrocketed by 2960.0% in 2022.
  • Anaptysbio's Accumulated Depreciation & Amortization (Quarter) stood at $619000.0 in 2021, then increased by 9.05% to $675000.0 in 2022, then dropped by 3.41% to $652000.0 in 2023, then fell by 7.06% to $606000.0 in 2024, then decreased by 29.37% to $428000.0 in 2025.
  • Its last three reported values are $428000.0 in Q3 2025, $288000.0 for Q2 2025, and $146000.0 during Q1 2025.